IMPROVEMENT OF THE COMPLEX OF MEASURES IN OVERWEIGHT WOMEN ON PRECONCEPTION PERIOD AND DURING PREGNANCY

Authors

DOI:

https://doi.org/10.11603/24116-4944.2023.2.14265

Keywords:

overweight women, preconception and antenatal care, inositol, insulin resistance, body fat mass, gestational weight gain, physical activity, lifestyle

Abstract

This aim of the study – to evaluate the effectiveness of the complex of measures in overweight women on preconception period and during pregnancy.

Materials and Methods. The study involved 140 overweight women (body mass index (BMI) 25.0–29.9 kg/m2): 68 women (the first group) received generally accepted standard preconception and antenatal care recommendations, 72 women (comparison group) received the proposed preconception and antenatal care measures. Anthropometry was performed, BMI was calculated, eating behavior, physical activity level (PA), body fat mass percentage (% FM), serum glucose and insulin concentrations were determined, and the insulin resistance index (HOMA-IR) was calculated. The proposed program of measures included: 1) lifestyle modification (correction of eating behavior and FA, intensive walking (≥7500 steps/day); 2) multivitamin complex, an inositol complex (myo-inositol – 550 mg, D-chiro-inositol – 13.8 mg, folic acid - 240 mg), cholecalciferol (2000 IU per day prophylactic dose for vitamin D deficiency, 4000 IU per day for deficiency of vitamin D). Data was analyzed using Statistica 12.0 (StatSoft Inc., USA).

Results and Discusion. The implementation of the proposed program of measures has been contributed to an increase the frequency of women with a high degree of eating behavior (p<0.05), and moderate level of FA (p<0.05), a decrease the frequency of women with sedentary activity (p<0.05), an increase in the percentage of pregnant with ≥7500 steps/day in 2.7 times and a decrease of <5000 steps/day women in 4.0 times compared to the first group (p<0.05). In the comparison group at the prepregnancy period there was a decrease in % FM compared to the indicators at the beginning of the study (29.03±1.33 vs. 32.99±1.46, p<0.05), which correlated with a decrease in body weight (r=0.87, p<0.001). During pregnancy in this group, there was a decrease in the elevation of % FM and a 2.1 times higher percentage of pregnant was diagnosed with the recommended gestational weight gain (GWG) compared to the first group (p<0.05). A lower HOMA-IR indicator was established in the first trimester compared to the prepregnancy level (p<0.05), and its levels both at the beginning of gestation and before delivery were lower compared to the first group in 1.3 and 1.6 times, respectively (in both cases p<0.05).

Conclusions. So, it has been proven that the proposed program of measures for overweight women, supplemented by measures to regulate the level of eating behavior and physical activity with the inclusion of the myo-inositol/D-chiro-inositol complex, multivitamin complex, cholecalciferol, that started 3-6 months before the conception and continued during pregnancy, for the mother was associated with a decrease in the initial high level of insulin resistance with a significant reduced indicator until the end of pregnancy, which allows to prevent excessive accumulation of FM and excessive GWG.

Author Biography

L. R. Maksymenko, Ivano-Frankivsk National Medical University

Department of Obstetrics and Gynecology, Ivano-Frankivsk National Medical University

 

References

Price, S. A, Sumithran, P., Nankervis A., Permezel M & Proietto J. (2019). Preconception management of women with obesity: A systematic review. Wiley Obesity reviews, 20(4), 510-526. DOI: https://doi.org/10.1111/obr.12804

Welfare, AIoHa. (2017). A рicture of overweight and obesity in Australia. Canberra: AIHW, 40.

Adwani, N., Fouly, H., Omer T. (2021). Assessing the impact of obesity on pregnancy and neonatal outcomes among Saudi women. Nursing Reports, 11(2), 279-290. DOI: https://doi.org/10.3390/nursrep11020027

Reichental, Z. L., O'Brien, V. M., (2022). Interventions to support women with overweight or obesity or gestational diabetes mellitus to initiate and continue breastfeeding: Systematic review and meta-analysis. Obes Rev, 23(3), e13371. DOI: https://doi.org/10.1111/obr.13371

Huo, N., Zhang, K., Wang, L., Wang, L. Lv. W., Cheng, W., Jia, G. (2021). Association of maternal body mass index with risk of infant mortality: a dose-response meta-analysis. Front Pediatr,12 (9), 650413. DOI: https://doi.org/10.3389/fped.2021.650413

Nartea, R., Mitoiu, B.I., Nica, A. S. (2019). Correlation between pregnancy related weight gain, postpartum weight loss and obesity: a prospective study. J Med Life, 12(2), 178-183. DOI: https://doi.org/10.25122/jml-2019-0015

Ostafiichuk, S. O., Henyk, N. I., Neyko, O. V., Snizhko, T. B., Rymarchuk, M. I., Vdovychenko, Yu. P. (2022). Materynsʹki adypokiny ta insulin yak biomarkery akushersʹkoyi ta perynatalʹnoyi patolohiyi u zhinok z nadlyshkovoyu masoyu tila. [Maternal adipokines and insulin as biomarkers of obstetric and perinatal pathology in overweight women]. Svit biolohiyi i medytsyny – The world of biology and medicine, 4(82), 133-138. [in Ukrainian] DOI: https://doi.org/10.26724/2079-8334-2022-4-82-133-138

Świderska, E., Strycharz, J., Wróblewski, A., Szemraj, J., Drzewoski, J., Śliwińska, A. (2020)/Role of PI3K/AKT pathway in insulin-mediated glucose uptake [Internet]. Blood Glucose Levels. IntechOpen; Available from: http://dx.doi.org/10.5772/intechopen.80402 DOI: https://doi.org/10.5772/intechopen.80402

Wondmkun, Y. T. (2020). Obesity, insulin resistance, and type 2 diabetes: associations and therapeutic implications. Diabetes Metab Syndr Obes, 13, 3611-3616. DOI: https://doi.org/10.2147/DMSO.S275898

Kim, S. Y., Park, E-S., Kim, H. W. (2020). Effectiveness of non-pharmacological interventions for overweight or obese infertile women: a systematic review and meta-analysis. Int J Environ Res Public Health, 17(20), 7438. DOI: https://doi.org/10.3390/ijerph17207438

Kandel, P., Lim, S., Pirotta, S., Skouteris, H., Moran, L. J., Hill, B. (2021). Enablers and barriers to women's lifestyle behavior change during the preconception period: a systematic review. Obes Rev, 22(7), e13235. DOI: https://doi.org/10.1111/obr.13235

Brown, H. K., Mueller, M., Edwards, S., Mill, C., Enders, J., Graves, L., Telner, D., Dennis, C. L. (2017). Preconception health interventions delivered in public health and community settings: A systematic review. Can J Public Health, 108, e388–e397. DOI: https://doi.org/10.17269/CJPH.108.6029

Lang, A. Y., Boyle, J. A., Fitzgerald, G. L., Teede, H., Mazza, D., Moran, L.J., Harrison, C. (2018). Optimizing preconception health in women of reproductive age. Minerva Ginecol, 70, 99–119. DOI: https://doi.org/10.23736/S0026-4784.17.04140-5

Lim, S., Harrison, C., Callander, E. (2022). Addressing obesity in preconception, pregnancy, and postpartum: a review of the literature. Curr Obes Rep, 11, 405–414. DOI: https://doi.org/10.1007/s13679-022-00485-x

Shrestha, A., Prowak, M., Berlandi-Short, V-M., Garay, J., Ramalingam, L. (2021). Maternal obesity: a focus on maternal interventions to improve health of offspring. Front Cardiovasc Med, 8, 696812. DOI: https://doi.org/10.3389/fcvm.2021.696812

Ostafiichuk, S. O. (2020). Optymizatsiya fizychnoyi aktyvnosti zhinok pid chas vahitnosti dlya poperedzhennya nadlyshkovoho hestatsiynoho zbilʹshennya masy tila. [Optimizing women's physical activity during pregnancy to prevent excessive gestational weight gain]. Zdorovʹe zhenshchyny – Women's health, 1(147), 56-9. [in Ukrainian] DOI: https://doi.org/10.15574/HW.2020.147.56

Bull, F. C., Al-Ansari, S. S., Biddle, S., Borodulin, K., Buman, M. P. (2020). World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med, 54(24), 1451-1462. DOI: https://doi.org/10.1136/bjsports-2020-102955

Kojta, I., Chacińska, M., Błachnio-Zabielska, A. (2020). Obesity, bioactive lipids, and adipose tissue inflammation in insulin resistance. Nutrients, 12(5), 1305. DOI: https://doi.org/10.3390/nu12051305

Zhabchenko, I. A., Syudmak, O. R., Lishchenko, I. S, Kovalenko, T. M., Bodnarenko, O. M. (2023). New therapeutic opportunities in improving antenatal management of obese women. Reproductive endocrinology, 2(68), 32-9. DOI: https://doi.org/10.18370/2309-4117.2023.68.58-64

Reznichenko, H., Reznichenko, Y. (2021). Inositol and folates in the restoration of reproductive function in women and prevention of congenital malformations: Literature review. Reproductive Endocrinology, 61, 95-100. DOI: https://doi.org/10.18370/2309-4117.2021.61.95-100

Gambioli, R., Forte, G., Buzzaccarini, G., Unfer, V., Laganà, A. S. (2021). Myo-Inositol as a key supporter of fertility and physiological gestation. Pharmaceuticals (Basel), 14(6), 504. DOI: https://doi.org/10.3390/ph14060504

Gambioli, R., Forte, G., Aragona, C., Bevilacqua, A., Bizzarri, M., Unfer, V. (2021). The use of D-chiro-Inositol in clinical practice. Eu Rev Med Pharm Sci, 25, 438-446.

Larner, J., Brautigan, D. L., Thorner, M. O. (2010). D-chiro-inositol glycans in insulin signaling and insulin resistance. Mol Med,16, 543-52. DOI: https://doi.org/10.2119/molmed.2010.00107

Nosenko OM. Mozhlyvosti zastosuvannya mio-inozytolu v reproduktyvniy medytsyni. (2020). [Possibilities of using myo-inositol in reproductive medicine] [Internet]. https://health-ua.com/multimedia/userfiles/files/2020/Akush_2_2020 /Akysh_2_2020_st22-23.pdf

Formoso, G., Baldassarre, M. P. A., Ginestra, F., Carlucci, M. A., Bucci, I., Consoli, A. (2019). Inositol and antioxidant supplementation: safety and efficacy in pregnancy. Diabetes Metab Res Rev, 35(5), e3154. DOI: https://doi.org/10.1002/dmrr.3154

Khmyl, M. S., Khmyl-Dosvald, A. S, Khmyl, S. V., Pidgayna, I. Y. (2018). Perspektyvy vykorystannya inozytolu v zhinok iz syndromom polikistoznykh yayechnykiv (ohlyad literatury). [Prospects for the use of inositol in women with polycystic ovary syndrome (literature review)]. Visnyk sotsialʹnoyi hihiyeny ta orhanizatsiyi okhorony zdorovʺya Ukrayiny – Herald of social hygiene and health care organization of Ukraine, 4(78), 82-89. [in Ukrainian]

Nakaz MOZ Ukrayini № 417 vid 15.07.2011 «Metodychni rekomendatsiyi shchodo orhanizatsiyi ambulatornoyi akushersʹko-hinekolohichnoyi dopomohy» DOI: https://doi.org/10.5664/JCSM.1216

Nakaz MOZ Ukrayini № 1437 vid 09.08.2022 «Normalʹna vahitnistʹ»

Institute of medicine (US) and National research council (US) committee to reexamine IOM Pregnancy weight guidelines. (2009). Determining optimal weight gain. In: KM Rasmussen, AL Yaktine, eds. Weight gain during pregnancy: Reexamining the guidelines. Washington, DC: National academies press, 241‐62.

Sagedal, L. R., Øverby, N. C., Bere, E., Torstveit, M. K., Lohne-Seiler, H., Småstuen, M. (2017). Lifestyle intervention to limit gestational weight gain: the Norwegian Fit for Delivery randomised controlled trial. BJOG, 124(1), 97-109. DOI: https://doi.org/10.1111/1471-0528.13862

Craig, C. L., Marshall, A. L., Sjostro, M. M., Bauman, A. E., Booth, M. L., Ainsworth, B. E. (2003). International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc, 35(8), 1381–1395. DOI: https://doi.org/10.1249/01.MSS.0000078924.61453.FB

Avramenko, T. V., Hovsieiev, D. O., Yavir, V. S., Mellina, I. M. (2021). Gestational diabetes: prevention during pregnancy, screening and diagnosis of the disease. Ukrainian Journal Health of Woman, 1(157), 26-32. DOI: https://doi.org/10.15574/HW.2021.157.26

Dalrymple, K. V., Flynn, A. C., Relph, S. A., O’Keeffe, M., Poston, L. (2018). Lifestyle interventions in overweight and obese pregnant or postpartum women for postpartum weight management: a systematic review of the literature. Nutrients, 10(11), 1704. DOI: https://doi.org/10.3390/nu10111704

Lindsay, K. L., Most, J., Buehler, K., Kebbe, M., Altazan, A. D., Redman, L. M. (2021). Maternal mindful eating as a target for improving metabolic outcomes in pregnant women with obesity. Frontiers in Bioscience-Landmark, 26(12), 1548-1558. DOI: https://doi.org/10.52586/5048

Clark, E., Isler, C., Strickland, D., McMillan, A. G., Fang, X., Kuehn, D., Ravisankar, S., Strom, C., May, L. E. (2019). Influence of aerobic exercise on maternal lipid levels and offspring morphometrics. Int J Obes, 43, 594–602. DOI: https://doi.org/10.1038/s41366-018-0258-z

Beetham, K. S., Giles, C., Noetel, M., Clifton, V., Jones, J. C., Naughton, G. (2019). The effects of vigorous intensity exercise in the third trimester of pregnancy: A systematic review and meta-analysis. BMC Pregnancy Childbirth, 19, 1–18. DOI: https://doi.org/10.1186/s12884-019-2441-1

Published

2024-01-03

How to Cite

Maksymenko, L. R. (2024). IMPROVEMENT OF THE COMPLEX OF MEASURES IN OVERWEIGHT WOMEN ON PRECONCEPTION PERIOD AND DURING PREGNANCY. Actual Problems of Pediatrics, Obstetrics and Gynecology, (2), 97–107. https://doi.org/10.11603/24116-4944.2023.2.14265

Issue

Section

OBSTETRICS AND GYNECOLOGY